Leukaemia Trial, Recruiting (NCT07313878)

Leukaemia Trial, Recruiting NCT07313878 Sponsor: University of Erlangen-Nürnberg Medical School Condition: Leukaemia

Printed from Voxsanity (voxsanity.com.au) — NCT07313878 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Leukaemia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with acute lymphatic leukemia (a type of blood cancer)
People who are aged 3 years old up to (but not including) 18 years old
People who have either finished their cancer treatment, or are on day 50 or earlier in their treatment plan, and have not received a medication called CPM before the first study examination

Who may not be able to join:

People who have a known history of allergic reactions to a contrast agent called SonoVue, or to other contrast agents (special dyes used in medical imaging)
People who have a tattoo in the area of the body being examined in the study
People who are pregnant
People who are currently breastfeeding
People for whom the use of SonoVue is otherwise medically not recommended (confirm with trial site)
People who are in a critical medical condition at the time of the study
People who have a known, clinically confirmed reduction in kidney function

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4991318533118

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07313878

Sponsor: University of Erlangen-Nürnberg Medical School

Phase: Not Applicable

Status: Recruiting

Condition: Leukaemia

Trial contact: +4991318533118

More information: https://clinicaltrials.gov/study/NCT07313878

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with acute lymphatic leukemia (a type of blood cancer)
People who are aged 3 years old up to (but not including) 18 years old
People who have either finished their cancer treatment, or are on day 50 or earlier in their treatment plan, and have not received a medication called CPM before the first study examination

Who may not be able to join:

People who have a known history of allergic reactions to a contrast agent called SonoVue, or to other contrast agents (special dyes used in medical imaging)
People who have a tattoo in the area of the body being examined in the study
People who are pregnant
People who are currently breastfeeding
People for whom the use of SonoVue is otherwise medically not recommended (confirm with trial site)
People who are in a critical medical condition at the time of the study
People who have a known, clinically confirmed reduction in kidney function

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Erlangen-Nürnberg Medical School

Registry

ClinicalTrials.gov

Start date

19 November 2025

Est. completion

19 November 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

CEUS Measurement 1; CEUS Measurement 2; CEUS Measurement 3; CEUS Measurement 4; CEUS Measurement 5; CEUS Measurement 6; CEUS Measurement 7; CEUS Measurement 8; CEUS Measurement 9; CEUS Measurement 10; CEUS Measurement 11; CEUS Measurement 12

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov